Jack Kain

Today’s podcast discussion will focus on appropriate steps to take to implement an effective Drug Monitoring Protocol in your practice. Key information shared will include:
Some of the key challenges facing clinicians today
Important steps to take for implementing a responsible drug monitoring protocol
How Quest can help
The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Senior Product Manager Jason Suomala, for the Quest Diagnostics Drug Monitoring and Toxicology division.

Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:
Mental Health disorders, diagnosis and prevalence
The challenge of medication adherence in mental health treatment
The impact of crises on the treatment of patients with mental health conditions
The role of clinical drug monitoring
 
The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.

Today’s podcast will cover testing for kratom, a drug of concern. Some of the key information shared will include:
What is kratom?
What is the chemical make-up?
Kratom toxicity and side effects
Testing for kratom
Why testing is important?
How to test for kratom
What testing will tell you
This episode features Jack Kain, PharmD, Quest Diagnostics medical science liaison, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. 

Today's podcast will cover why and when to use oral fluid testing. Some key topics shared will include:
What is oral fluid testing?
Comparison of oral fluid testing to other methods of testing
The benefits of oral fluid testing?
Some of the drugs oral fluid testing can identify?
How are the drugs identified?
How is the sample collected?
Discussion on some of the key collection issues
The episode features Les Edinboro, PhD, Quest Diagnostics executive science director, toxicology and drug monitoring, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. 

Today’s podcast will cover dangerous drug combinations and the role of clinical drug monitoring. Some of the key information that will be shared includes:
What are dangerous drug combinations
What practitioners and the public need to know about them
How dangerous drug combinations can work together to lead to side effects
Certain combinations predispose people to a greater risk of overdose and death
Combinations that can affect drug levels, creating a pharmacokinetic drug–drug interaction
Certain combinations that may result in excessive sedation
How drug testing can help
A tool to identify dangerous drug combinations
How drug testing identifies metabolites unique to a substance
This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. 

The podcast will cover screening (drug testing) for alcohol use in pain management and primary care. Topics covered will include:
Understand drug and alcohol misuse and abuse
Prevalence rates of alcohol use and misuse, and alcohol use disorders
Information on alcohol use, and concomitant use with opioids and benzodiazepines
Screening guidelines
Tools and types of tests
Testing for alcohol
Breathalyzer
Advances in testing
Biomarkers
Other considerations
Quest Diagnostics approach
This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. 

Today’s episode is on patients with substance use disorders in medication-assisted treatment (MAT). Some of the key points that will be covered include:
What is medication-assisted treatment
What are the goals of an MAT treatment program
Medications used in MAT treatment 
Drug testing during MAT
Purpose of drug testing
Types of drug testing
Specimen collection
Specimen validity
Test confirmation
This episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. 

Today, we will be talking about marijuana and marijuana-based products in order to: 
Understand drug testing for marijuana, and why it’s important
Examine marijuana used in concert with controlled medications for pain or ADHD
Give some general recommendations for therapeutic drug monitoring for marijuana in patients with chronic pain using controlled substances
For example, at a minimum such patients should be tested before opioid therapy begins, again within 1 to 3 months, and randomly over the next 12 months, and more frequently if there are unexpected results, or there are complaints or behavior changes in the patient 
The episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing your patients for marijuana.